Side-by-side comparison of AI visibility scores, market position, and capabilities
SF AI reading coach for K-3 children at $15M Goodwater Capital Series A Sep 2023; #5 Fortune Change the World List 2024, TIME Best Invention 2023; largest child speech AI dataset with decodable book subscription competing with HOMER for early literacy.
Ello is a San Francisco-based AI reading coach for young children — backed with $15 million in Series A funding in September 2023 led by Goodwater Capital — providing children in grades K-3 (ages 4-8) with a personalized reading tutoring experience that combines the world's largest child speech AI dataset with a library of decodable books to deliver individual phonics coaching through a subscription service ($24.99/month, five physical books shipped monthly). Named #5 on Fortune's Change the World List 2024 and one of TIME's Best Inventions of 2023, Ello's AI reads along with children in real time — detecting when a child misreads or struggles with a word, providing immediate corrective audio prompting, and adapting the difficulty of reading practice to each child's current phonics level. Founded to address the US childhood literacy crisis affecting approximately 16 million 4-8-year-old children learning to read.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.